|
|
Volumn 9, Issue 4, 2010, Pages 260-
|
|
Trial watch: Phase III success for novel Clostridium difficile antibiotic
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIDAXOMICIN;
VANCOMYCIN;
CLOSTRIDIUM DIFFICILE INFECTION;
DISEASE ASSOCIATION;
DRUG EFFICACY;
HUMAN;
INCIDENCE;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SHORT SURVEY;
ADULT;
ANTI-BACTERIAL AGENTS;
CLINICAL TRIALS, PHASE III AS TOPIC;
CLOSTRIDIUM DIFFICILE;
CLOSTRIDIUM INFECTIONS;
GLYCOSIDES;
HUMANS;
RECURRENCE;
|
|
EID: 84872136053
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3150 Document Type: Short Survey |
|
Times cited : (1)
|
|
References (0)
|